e 4031 has been researched along with Cancer of Pituitary in 2 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, YC | 1 |
| Wu, SN | 1 |
| Weinsberg, F | 1 |
| Bauer, CK | 1 |
| Schwarz, JR | 1 |
2 other studies available for e 4031 and Cancer of Pituitary
| Article | Year |
|---|---|
Block of erg current by linoleoylamide, a sleep-inducing agent, in pituitary GH3 cells.
Topics: 8,11,14-Eicosatrienoic Acid; alpha-Linolenic Acid; Amides; Animals; Arachidonic Acid; Arachidonic Ac | 2003 |
The class III antiarrhythmic agent E-4031 selectively blocks the inactivating inward-rectifying potassium current in rat anterior pituitary tumor cells (GH3/B6 cells).
Topics: Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Piperidines; Pituitary Neoplasms; | 1997 |